EnsiliTech named Finalist in the EntreConf Awards 2024 honouring Regional Entrepreneurs
Bristol, United Kingdom – 3rd July 2024. EnsiliTech, a pioneering biotechnology start-up, is thrilled to announce that it has been named a finalist in several categories of the EntreConf Awards 2024. The awards celebrate exceptional entrepreneurialism in multiple areas: Technology, Property, eCommerce, Sciences, Media, making this a remarkable achievement for the small biotech.
The Categories
1. Entrepreneur of the Year: Dr. Asel Sartbaeva, CEO of EnsiliTech, has been recognised for her outstanding leadership and contributions to the field of biotechnology. Dr. Sartbaeva's interdisciplinary expertise has been instrumental in advancing EnsiliTech's groundbreaking platform technology.
2. Female Entrepreneur: EnsiliTech proudly represents female entrepreneurship, with Dr. Asel Sartbaeva as CEO.
3. Pre-Revenue: EnsiliTech's innovative approach to vaccine stability, known as "EnsilicationTM," has garnered attention in the scientific community. By eliminating the need for refrigeration during vaccine transportation and storage, EnsiliTech aims to revolutionise global health outcomes.
4. Science: EnsiliTech's commitment to scientific excellence is evident through its revolutionary technology. The company's work has the potential to transform vaccine distribution worldwide.
5. Technology: EnsiliTech's innovative technology is poised to disrupt the vaccine logistics landscape. By ensuring the stability and efficacy of critical medical products without relying on cold chain infrastructure, EnsiliTech is at the forefront of innovation.
6. Young Entrepreneur: Dr. Matt Slade’s vision and dedication exemplify the spirit of young entrepreneurship. His dedication in building and advancing EnsiliTech's mission at such a young age sets an inspiring example for the next generation of innovators that the commercial journey can begin no matter your age or experience.[JS1] [MS2]
"We are honoured to be named finalists in these categories," said Dr. Asel Sartbaeva. "EnsiliTech's mission is to make a lasting impact on vaccine logistics and accessibility, and this recognition validates our commitment to innovation and excellence."
EnsiliTech extends its gratitude to the EntreConf Awards organisers and the panel of judges for this recognition. The awards ceremony, celebrating entrepreneurial excellence, will take place on 26th September at Aerospace Bristol.
About EnsiliTech
EnsiliTech is a Bristol-based startup, which spun out from the University of Bath in July 2022. In January 2023, EnsiliTech had finalised a first, oversubscribed, pre-seed investment round of £1.2M. This consisted of an Innovate UK grant and private investment from Science Angels Syndicate, Fink Family Office, QantX, and angels.
If you’d like to find out more about our technology, or explore partnership opportunities, contact hello@ensilitech.com .
For more information about EnsiliTech, visit www.ensilitech.com or connect with EnsiliTech on LinkedIn: EnsiliTech LinkedIn